At Easter our new Coolsculpting device arrived. Cryolipolysis (fat reduction through cold) is the innovative, low-risk and effective treatment for eliminating your fat deposits.

CoolSculpting® is a non-invasive and clinically proven procedure developed by Harvard scientists that reduces stubborn fat deposits on the body through targeted exposure to cold. CoolSculpting® is based on a safe, patented cooling technique and is the only cryolipolysis system with FDA* approval (+ CE in Europe). It is a gentle treatment method without surgical intervention, needles or accompanying diets. There is no downtime and no or minimal side effects.

Key Benefits of CoolSculpting®

For the first time, patients who want targeted fat reduction without surgery and the side effects of surgery are offered an alternative - CoolSculpting®.
With a customized treatment plan created by an authorized physician, impressive results can be achieved with CoolSculpting®.

How CoolSculpting® works

During the CoolSculpting® treatment, the applicator is placed on the fat depot determined by the doctor. The applicator pulls the fat deposit to be treated between two cooling plates, which ensure controlled cooling of the fat tissue. The skin surface and the surrounding tissue are protected. Since fat cells are sensitive to very low temperatures, a gradual, natural breakdown of the fat cells begins, which reduces the thickness of the fat layer. The result is a significant flattening of the fat deposit. Every patient is individual, which is why ZELTIQ™ recommends a customized treatment plan that is optimally tailored to the needs of the patient. Multiple treatments of one or more specific zones can further improve the result.

Effectiveness

CoolSculpting® leads to a clear and measurable reduction in the treated fat deposit(s). The treated fat cells disappear forever. The first results can be seen after only 3 weeks, the final result can be seen after one to three months at the latest. Every patient is unique, so ZELTIQ™ recommends a customized, individualized treatment plan. Multiple treatments of one or more zones can also improve the result.

Safety

CoolSculpting® is clinically proven to be safe and effective. The system features built-in safety mechanisms such as the patented Freeze Detect™ Sensor and is the only FDA-cleared, cold-based, non-invasive body contouring system. Patients can sleep, read or work on their laptop during the treatment, which can be performed lying down or sitting. CoolSculpting® does not require needles, diets or drugs, there is no downtime and no or only minor side effects. The treatment is carried out exclusively in authorized clinics under the supervision of the appropriate doctor.

Availability

CoolSculpting® is FDA approved and CE certified as a Class IIa medical system. The system is used by an elite network of international centers and clinics. To date, around 2.200 treatments have been carried out on around 60 systems in 1.000.000 countries worldwide. For a complete listing of all Authorized Dermatologists, Plastic Surgeons, and Aesthetic Clinics offering CoolSculpting®, visit www.coolsculpting.com. A list of German CoolSculpting® doctors can be found at www.coolsculpting.de.

Target group

CoolSculpting® is ideally suited for those patients who want to reduce their fat deposits in a targeted manner without exercising, dieting or surgery. The procedure is not suitable for weight reduction in patients who are severely overweight or underweight. Since every patient is individual, ZELTIQ™ recommends a customized treatment plan. Several treatments on one or more fat deposits can further optimize the result.

The scientific principle behind CoolSculpting®

The CoolSculpting® process developed by ZELTIQ™ is based on the scientific principle of cryolipolysis. Cryolipolysis is the result of a groundbreaking discovery by dermatologists Dr. Dieter Manstein and Dr. R. Rox Anderson of the Wellmann Center for Photomedicine at Massachusetts General Hospital in Boston, a Harvard Medical School training hospital.

ZELTIQ™ is the exclusive licensee of this patented technology and is therefore the only company that e